PhaseV

2 stories about PhaseV
CTech NY Conference Dr Raviv Pryluk

Here’s how PhaseV uses AI to optimize clinical trials to speed clinical development

27.03.25|James Spiro
CEO and Co-Founder Dr. Raviv Pryluk spoke to CTech after being named as one of the Top 10 Israeli startups to watch out for in 2025 at Calcalist’s Mind The Tech conference in New York. 
Raviv Pryluk PhaseV

PhaseV raises $15 million to optimize clinical trials with causal machine learning

24.10.23|CTech
The Israeli startup detects hidden signals in clinical data and extracts actionable insights for planning the next steps
ProfilesEngineServlet?at=39&mi=10&pt=18&dpi=1243103233&pai=cTech&dpn=4409&mt=1